DOI:
10.37988/1811-153X_2022_2_138The effectiveness of the use toothpaste R.O.C.S. PRO Moisturizing in patients with xerostomia
Downloads
Abstract
Creating a comfortable conditions of the oral mucosa and quality of life in patients with xerostomia is an urgent problem both for clinicians, who constantly note this symptom in many patients, and for manufacturers and suppliers of oral hygiene products. Patients with a symptom of «dry mouth», in addition to symptomatic replacement therapy with artificial analogues of saliva, need to optimize individual hygiene, because a violation of the qualitative or quantitative level of saliva will inevitably lead to a deterioration in the oral tissues. Therefore, the development of domestic oral hygiene products that reduce the severity of xerostomia manifestations and are economically affordable is of great importance in improving the quality of life of patients with dry mouth. This study presents the results of a study of a number of laboratory and consumer properties of R.O.C.S. PRO Moisturizing toothpaste for patients with xerostomia of varying severity. To assess the oral cavity condition before testing the paste, a clinical examination of 43 people (4 men and 39 women) aged 23 to 67 years was carried out. Participants were followed up twice: 1 and 4 weeks after the start of moisturizing toothpaste. According to pH-metry, after the using of this paste, there is a pronounced shift in the pH to the alkaline side, which is explained by the presence of a buffer system in the composition of the paste, which can neutralize the excess acidity of the oral fluid. An increase in the volume of salivation according to sialometry over the period of application of the paste (by an average of 0.6 ml) may be due to the presence of a natural mint salivary stimulating fragrance in the composition of the paste. Analysis of the results of the pH-metry study, showed acidification of the oral fluid compared to the generally accepted pH standard with a decrease in the volume of saliva in the oral cavity. The lowest pH in the observed patients was 4.7, with an intragroup average of 5.6. The evaluation of the pH-metry data of the oral fluid in dynamics against the background of the use of the paste showed the presence of a shift in its reaction to the alkaline side. Observation during the month revealed a gradual restoration of acid-base balance in the oral cavity, although there was no return to pH in the range of 6.8-7.4. The obtained results of positive dynamic changes in metabolic processes in the oral fluid against the background of the use of the developed paste give grounds for its broad recommendation in order to normalize the state of the oral mucosa and mineral metabolism in the enamel in patients with symptoms of xerostomia in a shorter time.Key words:
“dry mouth”, xerostomia, saliva, sialometry, pH-metry, R.O.C.S. PRO MoisturizingFor Citation
[1]
Akulovich A.V., Buzova E.V., Borovskaya A.B., Yakunina L.A., Kupets T.V., Matelo S.K. The effectiveness of the use toothpaste R.O.C.S. PRO Moisturizing in patients with xerostomia. Clinical Dentistry (Russia). 2022; 25 (2): 138—143. DOI: 10.37988/1811-153X_2022_2_138
References
- Arakelyan M.G. Comparative assessment of means to alleviate xerostomia: master’s thesis. Moscow, 2017. 134 p. (In Russ.).
- Arakelyan M.G., Tambovtseva N.V., Arzukanyan A.V. The main causes and clinical manifestations of xerostomia. Russian Journal of Dentistry. 2016; 2: 74—78 (In Russ.). eLIBRARY ID: 26040390
- Getman A.D. Clinical and laboratory characteristics of salivary glands and oral organs in patients who received radiotherapy for malignant head and neck tumors: master‘s thesis. Yekaterinburg, 2007. 123 p. (In Russ.).
- Millsop J.W., Wang E.A., Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017; 35 (5): 468—476. PMID: 28916028
- Tanasiewicz M., Hildebrandt T., Obersztyn I. Xerostomia of Various Etiologies: A Review of the Literature. Adv Clin Exp Med. 2016; 25 (1): 199—206. PMID: 26935515
- Gil-Montoya J.A., Silvestre F.J., Barrios R., Silvestre-Rangil J. Treatment of xerostomia and hyposalivation in the elderly: A systematic review. Med Oral Patol Oral Cir Bucal. 2016; 21 (3): e355—66. PMID: 27031061
- Derkacheva E.I. Clinical and laboratory substantiation of a new oral moisturizer for drug-induced xerostomia: master‘s thesis. Yekaterinburg, 2016. 123 p. (In Russ.).
- Barbe A.G. Medication-induced xerostomia and hyposalivation in the elderly: Culprits, complications, and management. Drugs Aging. 2018; 35 (10): 877—885. PMID: 30187289
- Hoseini A., Mirzapour A., Bijani A., Shirzad A. Salivary flow rate and xerostomia in patients with type I and II diabetes mellitus. Electron Physician. 2017; 9 (9): 5244—5249. PMID: 29038704
- Mauri-Obradors E., Estrugo-Devesa A., Jané-Salas E., Viñas M., López-López J. Oral manifestations of diabetes mellitus. A systematic review. Med Oral Patol Oral Cir Bucal. 2017; 22 (5): e586-e594. PMID: 28809366
- Montaldo L., Montaldo P., Papa A., Caramico N., Toro G. Effects of saliva substitutes on oral status in patients with Type 2 diabetes. Diabet Med. 2010; 27 (11): 1280—3. PMID: 20950386
- Velasco-Ortega E., Delgado-Ruiz R.A., López-López J. Dentistry and Diabetes: The Influence of Diabetes in Oral Diseases and Dental Treatments. J Diabetes Res. 2016; 2016: 6073190. PMID: 28119931
- López-Pintor R.M., Casañas E., González-Serrano J., Serrano J., Ramírez L., de Arriba L., Hernández G. Xerostomia, Hyposalivation, and Salivary Flow in Diabetes Patients. J Diabetes Res. 2016; 2016: 4372852. PMID: 27478847
- Tan E.C.K., Lexomboon D., Sandborgh-Englund G., Haasum Y., Johnell K. Medications that cause dry mouth as an adverse effect in older people: A systematic review and metaanalysis. J Am Geriatr Soc. 2018; 66 (1): 76—84. PMID: 29071719
- Donaldson M., Goodchild J.H. A systematic approach to xerostomia diagnosis and management. Compend Contin Educ Dent. 2018; 39 (suppl 5): 1—9; quiz 10. PMID: 30605344
- Baghizadeh Fini M. Oral saliva and COVID-19. Oral Oncol. 2020; 108: 104821. PMID: 32474389
- Fantozzi P.J., Pampena E., Di Vanna D., Pellegrino E., Corbi D., Mammucari S., Alessi F., Pampena R., Bertazzoni G., Minisola S., Mastroianni C.M., Polimeni A., Romeo U., Villa A. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19. Am J Otolaryngol. 2020; 41 (6): 102721. PMID: 32977063
- Farook F.F., Mohamed Nuzaim M.N., Taha Ababneh K., Alshammari A., Alkadi L. COVID-19 pandemic: oral health challenges and recommendations. Eur J Dent. 2020; 14 (S 01): S165-S170. PMID: 33233004
- Martín M., Marín A., López M., Liñán O., Alvarenga F., Büchser D., Cerezo L. Products based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia. Rep Pract Oncol Radiother. 2017; 22 (1): 71—76. PMID: 27920611
- Shang X., Pan H., Li M., Miao X., Ding H. Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol. 2011; 138 (1): 1—21. PMID: 21864666
- Adamczak M.I., Martinsen Ø.G., Smistad G., Hiorth M. Polymer coated mucoadhesive liposomes intended for the management of xerostomia. Int J Pharm. 2017; 527 (1—2): 72—78. PMID: 28522426
- Ballini A., Cantore S., Signorini L., Saini R., Scacco S., Gnoni A., Inchingolo A.D., De Vito D., Santacroce L., Inchingolo F., Dipalma G. Efficacy of sea salt-based mouthwash and xylitol in improving oral hygiene among adolescent population: A pilot study. Int J Environ Res Public Health. 2020; 18 (1): E44. PMID: 33374694
- Corrocher R., Tedesco F., Rabusin P., De Sandre G. Effect of human erythrocyte stromata on complement activation. Br J Haematol. 1975; 29 (2): 235—41. PMID: 33
- Collis R.W., Sheinbein D.M. Cocamidopropyl betaine is commonly found in hypoallergenic personal care products for children. J Am Acad Dermatol. 2020; 82 (5): 1245—1247. PMID: 31874208
- Spirk C., Hartl S., Pritz E., Gugatschka M., Kolb-Lenz D., Leitinger G., Roblegg E. Comprehensive investigation of saliva replacement liquids for the treatment of xerostomia. Int J Pharm. 2019; 571: 118759. PMID: 31622744
Downloads
Received
April 14, 2022
Accepted
May 24, 2022
Published on
June 1, 2022